title: Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature.
abstract: BACKGROUND
  Aging is accompanied by increasing vulnerability to pathologies such as atherosclerosis (ATH) and Alzheimer disease (AD). Are these different pathologies, or different presentations with a similar underlying pathoetiology?
  
  
  CONCLUSIONS
  Both ATH and AD involve inflammation, macrophage infiltration, and occlusion of the vasculature. Allelic variants in common genes including APOE predispose to both diseases. In both there is strong evidence of disease association with viral and bacterial pathogens including herpes simplex and Chlamydophila. Furthermore, ablation of components of the immune system (or of bone marrow-derived macrophages alone) in animal models restricts disease development in both cases, arguing that both are accentuated by inflammatory/immune pathways. We discuss that amyloid β, a distinguishing feature of AD, also plays a key role in ATH. Several drugs, at least in mouse models, are effective in preventing the development of both ATH and AD. Given similar age-dependence, genetic underpinnings, involvement of the vasculature, association with infection, Aβ involvement, the central role of macrophages, and drug overlap, we conclude that the two conditions reflect different manifestations of a common pathoetiology.
  
  
  RESULTS
  Infection and inflammation selectively induce the expression of cholesterol 25-hydroxylase (CH25H). Acutely, the production of 'immunosterol' 25-hydroxycholesterol (25OHC) defends against enveloped viruses. We present evidence that chronic macrophage CH25H upregulation leads to catalyzed esterification of sterols via 25OHC-driven allosteric activation of ACAT (acyl-CoA cholesterol acyltransferase/SOAT), intracellular accumulation of cholesteryl esters and lipid droplets, vascular occlusion, and overt disease.
  
  
  CONCLUSIONS
  We postulate that AD and ATH are both caused by chronic immunologic challenge that induces CH25H expression and protection against particular infectious agents, but at the expense of longer-term pathology.
authors.affiliation: State University of Pushchino, Prospekt Nauki, Pushchino 142290, Moscow Region, Russia. rlathe@pieta-research.org.
authors.forename: Richard
authors.initials: R
authors.lastname: Lathe
authors.forename: Alexandra
authors.initials: A
authors.lastname: Sapronova
authors.forename: Yuri
authors.initials: Y
authors.lastname: Kotelevtsev
mesh_terms: D000375:Aging / Q000378:metabolism / Q000473:pathology; D000544:Alzheimer Disease / Q000097:blood / Q000209:etiology* / Q000473:pathology; D016229:Amyloid beta-Peptides / Q000097:blood; D000818:Animals; D050197:Atherosclerosis / Q000097:blood / Q000209:etiology* / Q000473:pathology; D001921:Brain / Q000098:blood supply* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D006888:Hydroxycholesterols / Q000097:blood; D007249:Inflammation / Q000097:blood / Q000150:complications / Q000473:pathology; D018836:Inflammation Mediators / Q000097:blood*
chemical_list: D016229:Amyloid beta-Peptides; D006888:Hydroxycholesterols; D018836:Inflammation Mediators; C007997:25-hydroxycholesterol